USP Drug Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

 Analgesics
 Anesthetics
 Anti-Addiction/Substance Abuse Treatment Agents
 Antibacterials
 Anticonvulsants
 Antidementia Agents
 Antidepressants
 Antiemetics
 Antifungals
 Antigout Agents
 Anti-inflammatory Agents
 Antimigraine Agents
 Antimyasthenic Agents
 Antimycobacterials
 Antineoplastics
   Alkylating Agents
   Antiandrogens
   Antiangiogenic Agents
   Antiestrogens/Modifiers
   Antimetabolites
   Aromatase Inhibitors, 3rd Generation
   Enzyme Inhibitors
   Molecular Target Inhibitors
     Gefitinib
     Binimetinib
     Cobimetinib [DG:DG01825]
     Alectinib [DG:DG01625]
     Brigatinib
     Ceritinib
     Crizotinib
     Dabrafenib [DG:DG00721]
     Encorafenib
     Trametinib [DG:DG00723]
     Vemurafenib
     Acalabrutinib
     Ibrutinib
     Abemaciclib
     Palbociclib [DG:DG01831]
     Ribociclib [DG:DG02084]
     Ramucirumab
     Afatinib [DG:DG00717]
     Dacomitinib [DG:DG01793]
     Erlotinib [DG:DG00711]
     Osimertinib
     Sonidegib [DG:DG01854]
     Vismodegib
     Ivosidenib
     Ruxolitinib [DG:DG00719]
     Cabazitaxel [DG:DG00695]
     Everolimus
     Bosutinib [DG:DG00718]
     Dasatinib [DG:DG00714]
       D06414  Dasatinib (USAN)
     Imatinib [DG:DG00710]
     Nilotinib [DG:DG00716]
     Ponatinib [DG:DG00722]
     Lapatinib [DG:DG00715]
     Axitinib
     Cabozantinib [DG:DG01670]
     Lenvatinib [DG:DG01362]
     Pazopanib
     Regorafenib [DG:DG00720]
     Sorafenib [DG:DG00713]
     Sunitinib [DG:DG00712]
     Vandetanib
     Midostaurin
     Copanlisib [DG:DG01926]
     Duvelisib
     Idelalisib
     Niraparib
     Olaparib
     Rucaparib [DG:DG01864]
     Talazoparib [DG:DG01865]
     Venetoclax
     Belinostat
     Panobinostat [DG:DG01403]
   Monoclonal Antibody/Antibody-Drug Conjugate
   Retinoids
   Treatment Adjuncts
   Antineoplastics, Other
 Anti-Obesity Agents
 Antiparasitics
 Antiparkinson Agents
 Antipsychotics
 Antispasticity Agents
 Antivirals
 Anxiolytics
 Bipolar Agents
 Blood Glucose Regulators
 Blood Products and Modifiers
 Cardiovascular Agents
 Central Nervous System Agents
 Contraceptives
 Dental and Oral Agents
 Dermatological Agents
 Electrolytes/Minerals/Metals/Vitamins
 Gastrointestinal Agents
 Genetic or Enzyme Disorder: Replacement, Modifiers, Treatment
 Genitourinary Agents
 Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
 Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
 Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
 Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
 Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
 Hormonal Agents, Suppressant (Adrenal)
 Hormonal Agents, Suppressant (Pituitary)
 Hormonal Agents, Suppressant (Thyroid)
 Immunological Agents
 Infertility Agents
 Inflammatory Bowel Disease Agents
 Metabolic Bone Disease Agents
 Ophthalmic Agents
 Otic Agents
 Respiratory Tract/Pulmonary Agents
 Sexual Disorder Agents
 Skeletal Muscle Relaxants
 Sleep Disorder Agents

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: June 27, 2019
According to the USP Drug Classification 2019

» Japanese version